Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ENvue Medical, Inc.NAOV · Entity 8385 | Director · President | October 19, 2016 | October 20, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ENvue Medical, Inc.
Report date October 19, 2016 · Filed October 20, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $5.55 · Expires 2026-10-19 | Direct | 35,000 |
Reported balance
After 2016-10-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2016-10-19 · Grant · Acquired 35,000 · Balance 35,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 19, 2016 Filed Oct 20, 2016 20:09 UTC | ENvue Medical, Inc. NAOV · Entity 8385 | GrantOption to Purchase Common Stock · Derivative | 35,000 | $0.00 Strike: $5.55 | $0.00 |
DisclosureSEC source: 0001144204-16-128814 · v450896_4.xml · derivative · entry 1 Stern William · CIK 0001607801 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2026-10-19 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.